Elutia/$ELUT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Elutia
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Ticker
$ELUT
Sector
Primary listing
Employees
26
Headquarters
Website
Elutia Metrics
BasicAdvanced
$50m
1.18
$0.96
-
-
Price and volume
Market cap
$50m
52-week high
$2.64
52-week low
$0.50
Average daily volume
120k
Financial strength
Current ratio
2.048
Quick ratio
1.288
Long term debt to equity
16.403
Total debt to equity
18.729
Profitability
EBITDA (TTM)
-19.297
Gross margin (TTM)
56.33%
Net profit margin (TTM)
400.16%
Operating margin (TTM)
-160.16%
Effective tax rate (TTM)
-0.34%
Revenue per employee (TTM)
$480,000
Management effectiveness
Return on assets (TTM)
-26.39%
Return on equity (TTM)
314.09%
Valuation
Price to earnings (TTM)
1.177
Price to revenue (TTM)
3.857
Price to book
2.16
Price to tangible book (TTM)
2.28
Growth
Revenue change (TTM)
-47.47%
Earnings per share change (TTM)
-169.82%
3-year revenue growth (CAGR)
-12.74%
3-year earnings per share growth (CAGR)
-24.83%
Elutia News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs